CONCLUSION
This case demonstrates that minimally invasive mitral valve repair can be safely performed in patients with hemophilia. Using a comprehensive approach, including a FVIII level-controlled replacement therapy, a minimally invasive valve repair, and sinus rhythm restoration, allows to minimize the risk of complications in the perioperative and postoperative periods in patients with severe hemophilia A.